Google is bringing its Nano Banana AI image editor to Search, NotebookLM and Photos. It’ll be able to do a couple of new things, like add more style options to Video Overviews.

In this post, we’ll show how Kitsa, a health-tech company specializing in AI-driven clinical trial recruitment and site selection, used Amazon Quick Automate to transform their clinical trial site selection solution. Amazon Quick Automate, a capability of Amazon Quick Suite, enables enterprises to build, deploy and maintain resilient workflow automations at scale.

In this post, we explore how Amazon Quick Suite’s Model Context Protocol (MCP) client enables secure, standardized connections to enterprise applications and AI agents, eliminating the need for complex custom integrations. You’ll discover how to set up MCP Actions integrations with popular enterprise tools like Atlassian Jira and Confluence, AWS Knowledge MCP Server, and Amazon Bedrock AgentCore Gateway to create a collaborative environment where people and AI agents can seamlessly work together across your organization’s data and applications.

BigBear.ai, SoundHound AI, Tempus AI, Hut 8, Upstart, Fluence Energy, and Fermi are the seven Artificial Intelligence stocks to watch today, according to MarketBeat’s stock screener tool. “Artificial intelligence stocks” are shares of companies whose businesses are materially tied to the developmen

California Gov. Gavin Newsom approved mandatory monitoring and reminders when kids use chatbots. Child advocates backed a different bill.

This is Google’s latest image generation technology from within Gemini – now available in Search.

Deloitte’s Zora AI is now integrated with Oracle Fusion Cloud and can run on Oracle Cloud Infrastructure. The combination will help organizations deploy

Howard Marks discusses tech stock valuations, AI enthusiasm, and value investing in today’s market.

For a decade, innovators at the intersection of artificial intelligence (AI) and precision medicine have faced a stubborn paradox: the very breakthroughs in software and machine learning that enable early cancer detection and personalized therapy recommendations are often denied U.S. patent protection. Under the unpredictable Alice/Mayo framework, patent examiners and courts frequently categorize adaptive AI models as “abstract ideas,” equating them to mathematical exercises rather than technological advances deserving protection.